Published in Cardiovascular Device Liability Week, April 2nd, 2006
Under Prescription Drug User Fee Act (PDUFA) III, the FDA's goal is to review and act on the NDA by late October of 2006.
Point CEO Dr. Jerry Griffin said, "We believe that Cardiosphere may offer important advantages to patients, physicians and payers." If approved for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.